{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:22:45Z","timestamp":1790400165935,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,8,21]],"date-time":"2010-08-21T00:00:00Z","timestamp":1282348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10549-010-1125-3","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T05:20:11Z","timestamp":1282281611000},"page":"875-878","source":"Crossref","is-referenced-by-count":14,"title":["Maternal and paternal lineage double heterozygosity alteration in familial breast cancer: a first case report"],"prefix":"10.1007","volume":"124","author":[{"given":"Brunella","family":"Pilato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"De Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Danza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Lambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,21]]},"reference":[{"issue":"1\u20132","key":"1125_CR1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mrfmmm.2008.07.005","volume":"644","author":"S Tommasi","year":"2008","unstructured":"Tommasi S, Pilato B, Pinto R, Monaco A, Bruno M, Campana M, Digennaro M, Schittulli F, Lacalamita R, Paradiso A (2008) Molecular and in silico analysis of brca1 and brca2 variants. Mutat Res 644(1\u20132):64\u201370. doi: S0027-5107(08)00135-8","journal-title":"Mutat Res"},{"key":"1125_CR2","doi-asserted-by":"crossref","unstructured":"Diez O, Gutierrez-Enriquez S, Masas M, Tenes A, Yague C, Arcusa A, Llort G (2010) Identification of a new complex deleterious mutation in exon 18 of the brca2 gene in a hereditary male\/female breast cancer family. Breast Cancer Res Treat. doi: 10.1007\/s10549-010-0830-2","DOI":"10.1007\/s10549-010-0830-2"},{"key":"1125_CR3","doi-asserted-by":"crossref","unstructured":"Pilato B, Martinucci M, Danza K, Pinto R, Petriella D, Lacalamita R, Bruno M, Lambo R, D\u2019Amico C, Paradiso A, Tommasi S (2010) Mutations and polymorphic brca variants transmission in breast cancer familial members. Breast Cancer Res Treat. doi: 10.1007\/s10549-010-0861-8","DOI":"10.1007\/s10549-010-0861-8"},{"key":"1125_CR4","doi-asserted-by":"crossref","unstructured":"Sluiter MD, van Rensburg EJ (2010) Large genomic rearrangements of the brca1 and brca2 genes: Review of the literature and report of a novel brca1 mutation. Breast Cancer Res Treat. doi: 10.1007\/s10549-010-0817-z","DOI":"10.1007\/s10549-010-0817-z"},{"key":"1125_CR5","doi-asserted-by":"crossref","unstructured":"Zuradelli M, Peissel B, Manoukian S, Zaffaroni D, Barile M, Pensotti V, Cavallari U, Masci G, Mariette F, Benski AC, Santoro A, Radice P (2010) Four new cases of double heterozygosity for brca1 and brca2 gene mutations: Clinical, pathological, and family characteristics. Breast Cancer Res Treat. doi: 10.1007\/s10549-010-0853-8","DOI":"10.1007\/s10549-010-0853-8"},{"issue":"3","key":"1125_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.ejhg.5200948","volume":"11","author":"L Cortesi","year":"2003","unstructured":"Cortesi L, Turchetti D, Bertoni C, Zanocco-Marani T, Vinceti M, Silvestri C, Federico M, Silingardi V, Ferrari S (2003) Italian family with two independent mutations: 3358t\/a in brca1 and 8756dela in brca2 genes. Eur J Hum Genet 11(3):210\u2013214. doi: 10.1038\/sj.ejhg.52009485200948","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"1125_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-004-7704-4","volume":"91","author":"A Musolino","year":"2005","unstructured":"Musolino A, Naldi N, Michiara M, Bella MA, Zanelli P, Bortesi B, Capelletti M, Savi M, Neri TM, Ardizzoni A (2005) A breast cancer patient from Italy with germline mutations in both the brca1 and brca2 genes. Breast Cancer Res Treat 91(2):203\u2013205. doi: 10.1007\/s10549-004-7704-4","journal-title":"Breast Cancer Res Treat"},{"issue":"1\u20132","key":"1125_CR8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mrfmmm.2005.06.010","volume":"578","author":"S Tommasi","year":"2005","unstructured":"Tommasi S, Crapolicchio A, Lacalamita R, Bruno M, Monaco A, Petroni S, Schittulli F, Longo S, Digennaro M, Calistri D, Mangia A, Paradiso A (2005) Brca1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from apulia, Italy. Mutat Res 578(1\u20132):395\u2013405. doi: S0027-5107(05)00250-2","journal-title":"Mutat Res"},{"issue":"11","key":"1125_CR9","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G (2002) Brcapro validation, sensitivity of genetic testing of brca1\/brca2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701\u20132712","journal-title":"J Clin Oncol"},{"issue":"3","key":"1125_CR10","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1136\/jmg.2004.027243","volume":"42","author":"B Leegte","year":"2005","unstructured":"Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A, Leenders EP, Wesseling J, de Hullu J, Hoogerbrugge N, Ligtenberg MJ, Ardern-Jones A, Bancroft E, Salmon A, Barwell J, Eeles R, Oosterwijk JC (2005) Phenotypic expression of double heterozygosity for brca1 and brca2 germline mutations. J Med Genet 42(3):e20. doi: 42\/3\/e20","journal-title":"J Med Genet"},{"issue":"3","key":"1125_CR11","first-page":"505","volume":"60","author":"D Abeliovich","year":"1997","unstructured":"Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T (1997) The founder mutations 185delag and 5382insc in brca1 and 6174delt in brca2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60(3):505\u2013514","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1125_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00008469-200508000-00008","volume":"14","author":"G Rennert","year":"2005","unstructured":"Rennert G, Dishon S, Rennert HS, Fares F (2005) Differences in the characteristics of families with brca1 and brca2 mutations in Israel. Eur J Cancer Prev 14(4):357\u2013361. doi: 00008469-200508000-00008","journal-title":"Eur J Cancer Prev"},{"issue":"12","key":"1125_CR13","first-page":"3776","volume":"8","author":"JM Satagopan","year":"2002","unstructured":"Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K (2002) Ovarian cancer risk in Ashkenazi Jewish carriers of brca1 and brca2 mutations. Clin Cancer Res 8(12):3776\u20133781","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1125_CR14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-0004.2004.00400.x","volume":"67","author":"A Kataki","year":"2005","unstructured":"Kataki A, Gomatos I, Pararas N, Armakolas A, Panousopoulos D, Karantzikos G, Voros D, Zografos G, Markopoulos C, Leandros E, Konstadoulakis M (2005) Identification of germline brca1 and brca2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals\u2014correlation with clinicopathological data. Clin Genet 67(4):322\u2013329. doi: CGE400","journal-title":"Clin Genet"},{"key":"1125_CR15","unstructured":"De Benedetti VM, Radice P, Pasini B, Stagi L, Pensotti V, Mondini P, Manoukian S, Conti A, Spatti G, Rilke F, Pierotti MA (1998) Characterization of ten novel and 13 recurring brca1 and brca2 germline mutations in Italian breast and\/or ovarian carcinoma patients. Mutations in brief no. 178. Online. Hum Mutat 12(3):215"},{"issue":"1","key":"1125_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/humu.9003","volume":"19","author":"A Armakolas","year":"2002","unstructured":"Armakolas A, Ladopoulou A, Konstantopoulou I, Pararas B, Gomatos IP, Kataki A, Konstadoulakis MM, Stathopoulos GP, Markopoulos C, Leandros E, Gogas I, Yannoukakos D, Androulakis G (2002) Brca2 gene mutations in Greek patients with familial breast cancer. Hum Mutat 19(1):81\u201382. doi: 10.1002\/humu.9003","journal-title":"Hum Mutat"},{"issue":"1","key":"1125_CR17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-0004.2000.570111.x","volume":"57","author":"R Moslehi","year":"2000","unstructured":"Moslehi R, Russo D, Phelan C, Jack E, Antman K, Narod S (2000) An unaffected individual from a breast\/ovarian cancer family with germline mutations in both brca1 and brca2. Clin Genet 57(1):70\u201373","journal-title":"Clin Genet"},{"issue":"10","key":"1125_CR18","first-page":"2741","volume":"62","author":"DW Bell","year":"2002","unstructured":"Bell DW, Erban J, Sgroi DC, Haber DA (2002) Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both brca1 and brca2. Cancer Res 62(10):2741\u20132743","journal-title":"Cancer Res"},{"issue":"20","key":"1125_CR19","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of brca1 and brca2 among Ashkenazi Jews. N Engl J Med 336(20):1401\u20131408. doi: 10.1056\/NEJM199705153362001","journal-title":"N Engl J Med"},{"issue":"14","key":"1125_CR20","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S (1999) Prevalence and penetrance of brca1 and brca2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91(14):1241\u20131247","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1125_CR21","first-page":"467","volume":"10","author":"JM Satagopan","year":"2001","unstructured":"Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB (2001) The lifetime risks of breast cancer in Ashkenazi Jewish carriers of brca1 and brca2 mutations. Cancer Epidemiol Biomarkers Prev 10(5):467\u2013473","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"18","key":"1125_CR22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL (2002) Cancer risk estimates for brca1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94(18):1365\u20131372","journal-title":"J Natl Cancer Inst"},{"issue":"5645","key":"1125_CR23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in brca1 and brca2. Science 302(5645):643\u2013646. doi: 10.1126\/science.1088759302\/5645\/643","journal-title":"Science"},{"issue":"8","key":"1125_CR24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.293.8.964","volume":"293","author":"EB Claus","year":"2005","unstructured":"Claus EB, Petruzella S, Matloff E, Carter D (2005) Prevalence of brca1 and brca2 mutations in women diagnosed with ductal carcinoma in situ. JAMA 293(8):964\u2013969. doi: 293\/8\/964","journal-title":"JAMA"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1125-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1125-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:32:37Z","timestamp":1559219557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1125-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,21]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1125-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,21]]}}}